AU2021103658A4 - Iot based smart pandemic detection device and method for pandemic preventive measures - Google Patents
Iot based smart pandemic detection device and method for pandemic preventive measures Download PDFInfo
- Publication number
- AU2021103658A4 AU2021103658A4 AU2021103658A AU2021103658A AU2021103658A4 AU 2021103658 A4 AU2021103658 A4 AU 2021103658A4 AU 2021103658 A AU2021103658 A AU 2021103658A AU 2021103658 A AU2021103658 A AU 2021103658A AU 2021103658 A4 AU2021103658 A4 AU 2021103658A4
- Authority
- AU
- Australia
- Prior art keywords
- pandemic
- ssd
- psc
- cloud
- service
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 238000001514 detection method Methods 0.000 title claims abstract description 41
- 238000000034 method Methods 0.000 title claims abstract description 26
- 230000003449 preventive effect Effects 0.000 title claims abstract description 18
- 230000036541 health Effects 0.000 claims abstract description 39
- 201000010099 disease Diseases 0.000 claims abstract description 32
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims abstract description 32
- 230000007704 transition Effects 0.000 claims abstract description 10
- 208000025721 COVID-19 Diseases 0.000 claims description 45
- 208000024891 symptom Diseases 0.000 claims description 29
- 238000012360 testing method Methods 0.000 claims description 23
- 206010011224 Cough Diseases 0.000 claims description 22
- 238000004458 analytical method Methods 0.000 claims description 14
- 230000033001 locomotion Effects 0.000 claims description 10
- 230000000737 periodic effect Effects 0.000 claims description 10
- 230000029058 respiratory gaseous exchange Effects 0.000 claims description 10
- 238000002507 cathodic stripping potentiometry Methods 0.000 claims description 9
- 238000012216 screening Methods 0.000 claims description 8
- 238000003745 diagnosis Methods 0.000 claims description 7
- 230000008569 process Effects 0.000 claims description 6
- 206010037660 Pyrexia Diseases 0.000 claims description 5
- 238000010586 diagram Methods 0.000 claims description 5
- 230000004199 lung function Effects 0.000 claims description 5
- 230000037081 physical activity Effects 0.000 claims description 5
- 230000009471 action Effects 0.000 claims description 4
- 208000037656 Respiratory Sounds Diseases 0.000 claims description 3
- 208000030533 eye disease Diseases 0.000 claims description 3
- 230000004630 mental health Effects 0.000 claims description 3
- 230000036387 respiratory rate Effects 0.000 claims description 3
- 230000000007 visual effect Effects 0.000 claims description 3
- 238000002591 computed tomography Methods 0.000 description 14
- 238000012544 monitoring process Methods 0.000 description 10
- 241000711573 Coronaviridae Species 0.000 description 9
- 206010022000 influenza Diseases 0.000 description 8
- 230000034994 death Effects 0.000 description 7
- 231100000517 death Toxicity 0.000 description 7
- 206010041232 sneezing Diseases 0.000 description 7
- 206010035664 Pneumonia Diseases 0.000 description 6
- 238000013135 deep learning Methods 0.000 description 6
- 206010011409 Cross infection Diseases 0.000 description 5
- 206010029803 Nosocomial infection Diseases 0.000 description 5
- 241000700605 Viruses Species 0.000 description 5
- 238000007664 blowing Methods 0.000 description 5
- 230000036760 body temperature Effects 0.000 description 5
- 238000013507 mapping Methods 0.000 description 5
- 230000005236 sound signal Effects 0.000 description 5
- 208000036071 Rhinorrhea Diseases 0.000 description 4
- 206010039101 Rhinorrhoea Diseases 0.000 description 4
- 238000013473 artificial intelligence Methods 0.000 description 4
- 206010016256 fatigue Diseases 0.000 description 4
- 208000015181 infectious disease Diseases 0.000 description 4
- 238000011330 nucleic acid test Methods 0.000 description 4
- 230000000241 respiratory effect Effects 0.000 description 4
- 210000001519 tissue Anatomy 0.000 description 4
- 208000000059 Dyspnea Diseases 0.000 description 3
- 206010013975 Dyspnoeas Diseases 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 230000002685 pulmonary effect Effects 0.000 description 3
- 208000013220 shortness of breath Diseases 0.000 description 3
- 229960005486 vaccine Drugs 0.000 description 3
- 241001678559 COVID-19 virus Species 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 201000003176 Severe Acute Respiratory Syndrome Diseases 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 208000006673 asthma Diseases 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 201000006824 bubonic plague Diseases 0.000 description 2
- 230000000747 cardiac effect Effects 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 230000001149 cognitive effect Effects 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 230000001815 facial effect Effects 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 230000005980 lung dysfunction Effects 0.000 description 2
- 238000010801 machine learning Methods 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 238000000513 principal component analysis Methods 0.000 description 2
- 208000023504 respiratory system disease Diseases 0.000 description 2
- 238000003757 reverse transcription PCR Methods 0.000 description 2
- 238000012552 review Methods 0.000 description 2
- 238000004088 simulation Methods 0.000 description 2
- 238000013403 standard screening design Methods 0.000 description 2
- 238000010200 validation analysis Methods 0.000 description 2
- 241000256118 Aedes aegypti Species 0.000 description 1
- 208000019901 Anxiety disease Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 229940022962 COVID-19 vaccine Drugs 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 208000028399 Critical Illness Diseases 0.000 description 1
- 208000008960 Diabetic foot Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 201000011001 Ebola Hemorrhagic Fever Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 241000134304 Influenza A virus H3N2 Species 0.000 description 1
- 125000002066 L-histidyl group Chemical group [H]N1C([H])=NC(C([H])([H])[C@](C(=O)[*])([H])N([H])[H])=C1[H] 0.000 description 1
- 208000019693 Lung disease Diseases 0.000 description 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 241001115400 Zaire ebolavirus Species 0.000 description 1
- 241000907316 Zika virus Species 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- 238000011882 arthroplasty Methods 0.000 description 1
- 238000013528 artificial neural network Methods 0.000 description 1
- 238000003149 assay kit Methods 0.000 description 1
- 230000006399 behavior Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 238000009529 body temperature measurement Methods 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 208000030303 breathing problems Diseases 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000005792 cardiovascular activity Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 230000000739 chaotic effect Effects 0.000 description 1
- 230000003920 cognitive function Effects 0.000 description 1
- 238000013170 computed tomography imaging Methods 0.000 description 1
- 238000013527 convolutional neural network Methods 0.000 description 1
- 238000013480 data collection Methods 0.000 description 1
- 238000013136 deep learning model Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000008821 health effect Effects 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 238000009532 heart rate measurement Methods 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 208000037797 influenza A Diseases 0.000 description 1
- 208000037802 influenza A (H3N2) Diseases 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 238000009434 installation Methods 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- 230000031700 light absorption Effects 0.000 description 1
- 201000005202 lung cancer Diseases 0.000 description 1
- 208000020816 lung neoplasm Diseases 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000005541 medical transmission Effects 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 238000012806 monitoring device Methods 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 238000001579 optical reflectometry Methods 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 238000003909 pattern recognition Methods 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- 230000010349 pulsation Effects 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 238000012502 risk assessment Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 230000036559 skin health Effects 0.000 description 1
- 230000003595 spectral effect Effects 0.000 description 1
- 238000012706 support-vector machine Methods 0.000 description 1
- 201000010740 swine influenza Diseases 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000001960 triggered effect Effects 0.000 description 1
- 201000008827 tuberculosis Diseases 0.000 description 1
- 241000712461 unidentified influenza virus Species 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- 230000036642 wellbeing Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0002—Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network
- A61B5/0004—Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network characterised by the type of physiological signal transmitted
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0002—Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network
- A61B5/0015—Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network characterised by features of the telemetry system
- A61B5/0022—Monitoring a patient using a global network, e.g. telephone networks, internet
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/01—Measuring temperature of body parts ; Diagnostic temperature sensing, e.g. for malignant or inflamed tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording for evaluating the cardiovascular system, e.g. pulse, heart rate, blood pressure or blood flow
- A61B5/0205—Simultaneously evaluating both cardiovascular conditions and different types of body conditions, e.g. heart and respiratory condition
- A61B5/02055—Simultaneously evaluating both cardiovascular condition and temperature
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording for evaluating the cardiovascular system, e.g. pulse, heart rate, blood pressure or blood flow
- A61B5/024—Measuring pulse rate or heart rate
- A61B5/02416—Measuring pulse rate or heart rate using photoplethysmograph signals, e.g. generated by infrared radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording for evaluating the cardiovascular system, e.g. pulse, heart rate, blood pressure or blood flow
- A61B5/024—Measuring pulse rate or heart rate
- A61B5/02438—Measuring pulse rate or heart rate with portable devices, e.g. worn by the patient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/08—Measuring devices for evaluating the respiratory organs
- A61B5/0803—Recording apparatus specially adapted therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/08—Measuring devices for evaluating the respiratory organs
- A61B5/082—Evaluation by breath analysis, e.g. determination of the chemical composition of exhaled breath
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/08—Measuring devices for evaluating the respiratory organs
- A61B5/0823—Detecting or evaluating cough events
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/08—Measuring devices for evaluating the respiratory organs
- A61B5/087—Measuring breath flow
- A61B5/0878—Measuring breath flow using temperature sensing means
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/74—Details of notification to user or communication with user or patient ; user input means
- A61B5/7465—Arrangements for interactive communication between patient and care services, e.g. by using a telephone network
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/80—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for detecting, monitoring or modelling epidemics or pandemics, e.g. flu
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16Y—INFORMATION AND COMMUNICATION TECHNOLOGY SPECIALLY ADAPTED FOR THE INTERNET OF THINGS [IoT]
- G16Y10/00—Economic sectors
- G16Y10/60—Healthcare; Welfare
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B2562/00—Details of sensors; Constructional details of sensor housings or probes; Accessories for sensors
- A61B2562/02—Details of sensors specially adapted for in-vivo measurements
- A61B2562/0204—Acoustic sensors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B2562/00—Details of sensors; Constructional details of sensor housings or probes; Accessories for sensors
- A61B2562/02—Details of sensors specially adapted for in-vivo measurements
- A61B2562/0219—Inertial sensors, e.g. accelerometers, gyroscopes, tilt switches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B2562/00—Details of sensors; Constructional details of sensor housings or probes; Accessories for sensors
- A61B2562/02—Details of sensors specially adapted for in-vivo measurements
- A61B2562/0271—Thermal or temperature sensors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording for evaluating the cardiovascular system, e.g. pulse, heart rate, blood pressure or blood flow
- A61B5/024—Measuring pulse rate or heart rate
- A61B5/02405—Determining heart rate variability
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/103—Measuring devices for testing the shape, pattern, colour, size or movement of the body or parts thereof, for diagnostic purposes
- A61B5/11—Measuring movement of the entire body or parts thereof, e.g. head or hand tremor or mobility of a limb
- A61B5/1112—Global tracking of patients, e.g. by using GPS
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A90/00—Technologies having an indirect contribution to adaptation to climate change
- Y02A90/10—Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Medical Informatics (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Pathology (AREA)
- Veterinary Medicine (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- Physics & Mathematics (AREA)
- Heart & Thoracic Surgery (AREA)
- Physiology (AREA)
- Cardiology (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- Computer Networks & Wireless Communication (AREA)
- Primary Health Care (AREA)
- Nursing (AREA)
- Bioethics (AREA)
- Business, Economics & Management (AREA)
- Accounting & Taxation (AREA)
- Development Economics (AREA)
- Economics (AREA)
- General Business, Economics & Management (AREA)
- Computing Systems (AREA)
- Data Mining & Analysis (AREA)
- Databases & Information Systems (AREA)
- Measuring And Recording Apparatus For Diagnosis (AREA)
Abstract
The present invention provides for an IoT-based smart pandemic detection device
and method based on a cloud-oriented architecture - Pandemic Preventive Measure as a
Service (PPMaaS) network for early tracking of any pandemic disease affected populations,
deploying in crowd transition areas and taking precautions by contacting nearest relevant
hospitals to access treatment immediately based on the condition of the patients, wherein the
device based on an Al enabled cloud computing based framework comprising Smart
Pandemic Determiner (SPD) under Pandemic Service Controller (PSC) expertise, operates
from sample collection to detection phase based on the available resources provided by the
respective cloud service provide (CSP) and sends the result to the Government Health
Administration System (GHAS) through nearest Sanatorium or Health Centre (SHC) for
preventive measure.
Page 4 of 4
START
No
PSC checks for SSD's
authentication & SLA
Yes
CSP checks for PSC's No
authentication & SL A
Analysed Result<= Threshold
No
Yes
Yes Check the availability
of the Client
4No
Figure 4. Flowchart of PPMaaS Model
Description
Page 4 of 4
No PSC checks for SSD's authentication & SLA
Yes
CSP checks for PSC's No authentication & SL A
Analysed Result<= Threshold No Yes
Yes Check the availability of the Client
4No
Figure 4. Flowchart of PPMaaS Model
The present invention provides for an IoT-based smart pandemic detection device and method based on a cloud-oriented architecture - Pandemic Preventive Measure as a Service (PPMaaS) network for early tracking of any pandemic disease affected populations, deploying in crowd transition areas and taking precautions by contacting nearest relevant hospitals to access treatment immediately based on the condition of the patients, wherein the device based on an Al enabled cloud computing based framework comprising Smart Pandemic Determiner (SPD) under Pandemic Service Controller (PSC) expertise, operates from sample collection to detection phase based on the available resources provided by the respective cloud service provide (CSP) and sends the result to the Government Health Administration System (GHAS) through nearest Sanatorium or Health Centre (SHC) for preventive measure.
Through a historical viewpoint, the world has seen a number of devastating occurrences at various times, some with unparalleled impacts. One of the worst cases was the Black Death of the 14th century that killed an estimated 100-200 million people (Duncan C J, Scott S 2005 What caused the black death? Postgrad. Med. J., 81, 315. (CrossRef) (PubMed)). Primary influenza outbreaks (Flu) have occurred in recent years, including: the first (HINI influenza virus, or 'Spanish Flu') reported in 1918 (around 500 million deaths), originating in Etaples, France (Martini M, Gazzaniga V, Bragazzi N L, BarberisI2019 The spanish influenza pandemic: A lesson from history 100 years after 1918 J. Prev. Med. Hyg., 60, E64-E67); followed by influenza A subtype H2N2 ('Asian Flu') originating in China in 1957-1958 (1.1 million deaths); followed by influenza A (H3N2) originating in China in 1968 (1 million deaths) Then, in the United States, the 2009 HINI influenza (or swine flu) virus (12,469 deaths). Other outbreaks include SARS (or Severe Acute Respiratory Syndrome), which broke out in 2003 (774 deaths) in China's Guangdong Province; the 2014 Ebola (Zaire ebola virus) virus (11,315) in Zaire (now the Democratic Republic of Congo); the 2015 Zika Virus spread by the Brazilian Aedes aegypti mosquito; and the latest corona virus in 2020 that originated in Wuhan, China.
The whole world has focused closely on an outbreak of respiratory illness caused by a novel corona virus. The virus that causes COVID-19 is transmitted mainly by droplets that are generated when a person is infected with cough, sneezing, or exhales.
The viral disease COVID-19 (Corona virus disease 2019) with the symptom of extreme acute respiratory syndrome corona virus 2 (SARS-CoV-2) was first detected at Wuhan, China in December 2019, resulting in a continuing pandemic. There were millions cases reported since June 2020, resulting in huge deaths across 188 countries. There are no full-proof vaccines or effective antiviral therapies for COVID-19 according to the World Health Organization (WHO) report, though some vaccines are available.
In this pandemic scenario, a compulsory test must be considered for a large number of citizens in all countries, which may not be accessible for all individuals or may not be supported by the government due to the availability and expense of the test kit or any other testing tool or procedures that require time to install and use it for community use.
Therefore, there is a need in the art for an improved IoT-based smart pandemic detection device and method for pandemic prevention and control method.
In an aspect according to the present invention, it relates to an IoT-based smart pandemic detection device on a cloud-oriented architecture - Pandemic Preventive Measure as a Service (PPMaaS) network for early tracking of any pandemic disease affected populations, deploying in crowd transition areas and taking precautions by contacting nearest relevant hospitals to access treatment immediately based on the condition of the patients, wherein the device based on an Al enabled cloud computing based framework comprising Smart Pandemic Determiner (SPD) under Pandemic Service Controller (PSC) expertise, operates from sample collection to detection phase based on the available resources provided by the respective cloud service provide (CSP) and sends the result to the Government Health Administration System (GHAS) through nearest Sanatorium or Health Centre (SHC) for preventive measure.
In an embodiment, the device collects data from wide range of sensors such as temperature, cameras, inertial, proximity, microphones, colour, humidity, and likes.
In an embodiment, the Al enabled cloud computing based framework combines the usage of the sensors with cloud environment, converted it into a smarter portable system to gain more access and analyse power for COVID-19 like pandemic detection.
In an embodiment of the device according to the present invention, - to calculate different health issues, such as respiratory rate, heart rate, heart rate variability and health issues like skin & eye disease a advanced day-to-day sensors is used; - to track both the 'heart rate' and the 'rate of Respiration' the front and rear camera sensors of a smart phone is used and wherein 'photoplethysmogram (PPG) fingertip signal' from the top of the 'rear-facing camera' is used to achieve the heart rate; - for estimation of heart rate and heart rate variability through bare skin visual 'photoplethysmogram (PPG) signal' camera and microphone are mutually being used; - to predict fever, the sensor temperature-fingerprint is used; - to detect nasal symptoms, the application software Listen-to-Nose is used; - to test the lung function "SpiroSmart" is microphone based application software is used; - to detect a coughing and respiratory sound microphone sensor is used; - to assess mental health and physical activity and movement, embedded sensors like accelerometer, light, GPS, microphone etc. are used.
In an embodiment, the Cloud Service Provider (CSP) provides storage or software or hardware or network infrastructure to the customers through SaaS or IaaS or PaaS.
In an embodiment, the Government can create a special unit to track and deal with the pandemic situation.
In an embodiment, for spot diagnosis of the disease, a small device made by sensors connected to the cloud environment is used to sense data.
In an embodiment, for maintaining a smooth contact between SSD and CSP, PSC plays a major role as it compelled to register SSD and CSP's before assigning resources to the cloud server and to avoid potential conflict; and wherein after receiving the periodic signals from the CSPs, SPD will use the available cloud resources and will be able to collect data from SSD, analyze it and eventually identify the disease itself.
In an embodiment, the device provides for a portable testing device with an efficient interface that can be incorporated as part of the patient safety management system into medical and home equipment
In another aspect, the invention provide for an IoT-based smart pandemic detection method on a cloud-oriented architecture - Pandemic Preventive Measure as a Service (PPMaaS) network for early tracking of any pandemic disease affected populations, deploying in crowd transition areas and taking precautions by contacting nearest relevant hospitals to access treatment immediately based on the condition of the patients, wherein it comprises the following SCPD (Smart Cloud Pandemic detection) algorithm: 1. Pandemic Service Controller (PSC) offers preliminary detection of Pandemic disease using Smart Screening Device (SSD) through Smart Pandemic Determiner (SPD) in cloud environment 2. SSD may be installed in important places 3. SSD collects symptoms from the Clients 4. SSD requests to PSC for diagnosing 5. PSC checks for the SSD's authentication and Service Level Agreements (SLA) 6. If Authentic 6.1 Service accepted and acknowledgement sends to the SSD 6.2 PSC requests to the intended CSP for getting the on-demand cloud resources 6.3 CSP checks for the PSC's authentication and SLA 6.4 If bona fide 6.4.1 Service established and acceptance message sends to PSC 6.4.2 Based on the agreement CSP sends the periodic signals / resource details to Smart Pandemic Determiner (SPD) 6.4.3 SPD store the record details in a log file 6.4.4 Go to step 8 6.5 Else 6.5.1 Message - "Not acknowledged for services" back to the PSC 6.5.2 Go to step 6.2 7. Else 7.1 Message - "Not accepted for services" returns to the SSD 7.2 Go to step 4
8. SPD collects the client's symptoms from the SSD by its Fetching module 9. SPD fetches the periodic record details about the resources from its log file 10. Based on the collected symptoms SPD analysis on the data by its Testing module 10.1 If within Threshold 10.1.1 "Not Infected" -- message returned to the SSD as well as to the Client 10.1.2 Go to step 11 10.2 Else 10.2.1 SPD trace the current location of the infected person 10.2.2 "Infected" -- message returned to the SSD, to the Client, as well as to the nearest Sanatorium / Health Centre (SHC) with details about the Client 11. Check for the availability of the client 12. If client exists 12.1 Go to step 3 13. Else 13.1 Go to step 14 14. SHC sends the pandemic reports to the Government Health Management System (GHAS) 15. GHAS takes necessary actions 16. End
Figure 1. represents the schematic representation of the proposed Service Model (PPMaaS) including basic Cloud Service Model
Figure 2. represents the schematic representation of the proposed Architecture of Pandemic Preventive Measure as a service (PPMaaS) Model
Figure 3. represents the Process Flow Diagram of Smart Pandemic Determiner (SPD)
Figure 4. represents the Flowchart of PPMaaS Model
The present invention is directed towards an IoT-based smart pandemic detection device on a cloud-oriented architecture - Pandemic Preventive Measure as a Service (PPMaaS) network for early tracking of any pandemic disease (such as COVID19) affected populations, deploying in crowd transition areas and taking precautions by contacting nearest relevant hospitals to access treatment immediately based on the condition of the patients.
For this proposed IoT-based Smart Pandemic Detection Device deploying low-cost and less effort in various heavy public transition areas, an infected person can be monitored remotely from anywhere in the world and appropriate steps can be taken to apply health / medical recommendations recommended by competent authorities to spotted infected individuals. Through this smart screening process, we will protect from cross-infection other uninfected persons. Therefore, the government may take the steps for compulsory installation of such IOT based smart device as a preventive action at appropriate places to identify and track the infected persons.
The world has seen a variety of catastrophic events at various times from a historical point of view, some with unprecedented impacts, as discussed above. The novel corona virus (COVID 19) of respiratory disease - an outbreak was closely targeted worldwide which is transmitted mainly through droplets formed when a person is infected with cough, sneezing, or exhales. One can get infected with breathing in the virus if he or she is close to someone affected by COVID-19 or touches a contaminated surface by eyes, nose or mouth. The common symptoms including cough, Fever, shortness of breath, fatigue, smell, taste and loss of sense, but some patients often suffer from anxiety and discomfort, inflammation of the nose, runny nose, sore throat or diarrhea. Some individuals affected with COVID-19 have mild symptoms breathing problems, and they live without medication but elderly people and those with ongoing health issues such as heart disease, diabetes, chronic disease and cancer are also more likely to develop serious medical condition. Within the first three days of symptom onset, it is most contagious but it can widen even from people who have no symptoms before symptoms start (How COVID-19 Spreads 2 April 2020 Centers for Disease Control and Prevention (CDC) (Archivedfrom the original on 3 April 2020. Retrieved 3 April 2020) COVID 19 length of the incubation (time from symptoms to infection) varies between 1 and 14 days. According to WHO, almost 80 per cent of confirmed patients recover from the disease without significant complications, but one in six users of COVID-19 will get critically ill and encounter breathing difficulties. In more serious cases, disease can lead to acute pneumonia and other complications which can be handled only in higher-degree facilities (District Hospitals and above). In a few cases, this can also cause death.
According to an embodiment, the device and the method according to the present invention would prevent and slow down transmission of COVID-19 or similar contagious diseases for mass people on the spot by smart screening devices that can help diagnose this disease early on. A wide range of sensors such as temperature, cameras, inertial, proximity, microphones, colour, humidity, and many others are available on the market. The inventors of the present invention have combined the usage of these sensors with cloud environment, converted it into a smarter portable system to gain more access and analyse power for COVID-19 like pandemic detection.
In the Al enabled Cloud computing based proposed framework used in the device and the method according to the present invention, the Smart Pandemic Determiner (SPD) under Pandemic Service Controller (PSC) expertise not only from sample collection to detection phase based on the available resources provided by the respective Cloud Service Provider (CSP), and finally take the responsibility to send the result to the Government Health Administration System (GHAS) through nearest Sanatorium or Health Centre (SHC) for preventive measure.
People fight the pandemics at different times from ancient times to dates. Recently, the entire world has concentrated closely on an epidemic of respiratory disease triggered by a novel corona virus (COVID-19), get troubled worldwide, and kill the lives of people .Governments in a number of countries have taken measures to reduce the COVID-19 pandemic effect. During this immense and chaotic time, globally, scientists are working relentlessly to find a vaccine. Candidates for the COVID-19 vaccine, as well as other candidates for preclinical production and testing are currently in step 1-3 studies. In this circumstance almost all countries around the world are struggling together just to monitor the corona virus outbreak COVID-19. So many techniques such as "NAT (Nucleic Acid Test)", and "CT (Computed Tomography)" are available to diagnose COVID-19 corona virus disease, where NAT is used to classify various sequences of nucleic acid and organism types, specifically blood, tissue, or urine related diseases caused by a virus or bacteria. On the other hand, CT scanning is the most efficient and realistic way to detect the extent and degree of inflammation of the lung (Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, Wang B, Xiang H, Cheng Z, Xiong Y et al. 2020 (Clinical characteristicsof 138 hospitalizedpatients with 2019 novel coronavirus-infectedpneumonia in wuhan, china)), whereas detection kits and NAT technique are becoming critical to detect COVID-19 virus. The inclusion of regular clinical diagnostic presentations for radiographic pneumonia in the province of Hubei reported by National Health Commission of China (http://www.chinadaily.com.cn/m/chinahealth/index.html) as to diagnosis the severity of COVID-19 pneumonia by the key images of CT scan. The pandemic COVID-19 and the resulting enormous demand for treatment have inspired companies, academics and researchers to develop methods of detection that are highly efficient, smarter, and more reliable. A smart method of CT image reading system for the COVID-19 revealed by Ping, a Smart Healthcare device that can interpret findings at a precision rate above 90 percent in around 15 seconds (https:/www.bioworld.com/articles/433530-china-uses-ai-in-medical-imaging-to-speed up-covid-19-diagnosis). On the other side, of course neither the 'Reverse Transcription Polymerase Chain Reaction (RT-PCR)' nor the COVID-19 'CT scans' diagnosis are well suited (Bini S A 2018 Artificial intelligence, machine learning, deep learning, and cognitive computing: What do these terms mean and how will they impact health care? J Arthroplasty, 33, 2358-2361). In fact, with advances in computational capabilities and widespread use of Al, machine learning, big data like technologies embedded with cloud computing, it has become possible to collect and analyse vast amounts of data from various sources in real time, and to make informative predictions of it (Azmak , Bayer H, Caplin A, Glimcher P, Koonin S, PatrinosA 2015 Using big data to understand the human condition: The kavli human project. Big Data, 3, 173-188). A deep learning based Al algorithm with high resolution CT images (Chen J, Wu L, Zhang J, Zhang L, Gong D, Zhao Y, Hu S, Wang Y, Hu X, Zheng B et al. 2020 Deep learning-based model for detecting 2019 novel coronavirus pneumonia on high-resolution computed tomography: a prospective study medRxiv) has developed for detection of COVID-19. For detection of COVID-19, CT images of the volumetric chest analysed by 'COVNet (COVID-19 neural network detection)', the three dimensional deep learning technique has been used (Li L, Qin L, Xu Z, Yin Y, Wang X, Kong B, Cao K 2020. Artificial intelligence distinguishes COVID-19 from community acquiredpneumonia on chest CT. Radiology, 200905). A convolutionary ResNet-50 model called COVNet which takes its inputs as a sequence of CT segments and the CT image class labels determines its output and demands the proposed model is more capable to detect COVID-19 due to its AUC value 0.96 (He K, Zhang X, Ren S, Sun J 2016 Deep residual learningforimage recognition. In Proc. of the IEEE Conf on Computer Vision and PatternRecognition (pp. 770-778)). To detect cases of corona virus using pulmonary CT images another location-attention system concatenation with the three dimensional CNN ResNet-18 network - a deep learning method is proposed in (Xu X, JiangX, Ma C, Du P, Li X, Lv S, Li Y 2020. Deep learning system to screen coronavirus disease 2019 pneumonia arXivpreprintarXiv:2002.09334). Various types of COVID-19 CT imaging were found in (Kanne J P 2020 Chest CT findings in 2019 novel coronavirus (2019-nCoV) infections from Wuhan, China: key points for the radiologist. Radiology, 200241). Another deep learning model derived from customized stacked auto encoder is used to guess COVID-19 cases throughout China.
For assessing the risk of infection at the community level for a given geographic area, a-Satellite another Al-based prototype system is proposed (Ye Y, Hou S, Fan Y, Qian Y, Zhang Y, Sun S, Laparo K 2020 Satellite: An AI-driven system and benchmark datasetsforhierarchicalcommunity level risk assessment to help combat COVID-19. arXiv preprint arXiv:2003.12232). Social media data for a specified region could be inadequate to being enriched by the conditional adversarial generative networks for knowing COVID-19's public awareness (Mirza M, Osindero S 2014 Conditional generative adversarial nets. arXiv preprint arXiv:1411.1784). To estimate the risk indexes aggregate information from the given city's locality areas, an auto encoder model of a heterogeneous graph is then configured. Again, a stochastic agent-based discrete model called "ACEMod (Australian Census-based Epidemic Model)" is used to model the COVID-19 pandemic, previously used for influenza pandemic simulation, based on main disease transmission parameters across Australia (Cliff 0 M, Harding N, Piraveenan M, ErtenE. Y, Gambhir M, Prokopenko M 2018 Investigatingspatiotemporaldynamics and synchrony of influenza epidemics in Australia:An agent-based modelling approach. Simulation Modelling Practice and Theory, 87, 412-431). The best solution the model suggests is to incorporate foreign entry, case separation and social distancing constraints with 80 percent or higher enforcement in at least 13 weeks. For COVID-19 infection risk prediction, incorporating the concept of susceptible infected disease a hybrid Al model is proposed. For better understanding and manage the worldwide public health during the COVID-19 pandemic, another Al model based upon some standardisation protocols and data sharing techniques is proposed (Allam Z, and Jones D S 2020, March On the coronavirus (COVID 19) outbreak and the smart city network: universal data sharing standards coupled with artificial intelligence (AI) to benefit urban health monitoring and management. In Healthcare (vol. 8, no. 1, p. 46)). In addition the COVID-19 is detected by means of medical detection kits. But that method is expensive, requiring a diagnosis to be installed. Now a day, a lot of sensors on the market with strong computing capabilities can be constantly sensed awareness of day-to-day activities. For instance, the temperature-fingerprint sensor can be used to sense the body temperature to predict fever level (Maddah E, and Beigzadeh B 2020. Use of a smartphone thermometer to monitor thermal conductivity changes in diabeticfoot ulcers: a pilot study. Journal of Wound Care, 29(1), 61-66). On the other hand, inertial sensors can be used to detect human fatigue level where Images and videos taken from the camera or data taken from on board inertial sensors. Similarly, Story et al. (Aldridge R W, Smith C M, Garber E, Hall J, Ferenando G, AbubakarI2019 Smartphone enabled video-observed versus directly observed treatmentfor tuberculosis: a multicentre, analyst blinded, randomised, controlled superiority trial. The Lancet, 393(10177), 1216-1224) use Smartphone videos to predict nausea, while use camera images and measurements of inertial sensors used by Lawanont et al. (Inoue M, Mongkolnam P, Nukoolkit C 2018 Neck posture monitoring system based on image detection and smartphone sensors using the prolonged usage classification concept IEEJ Transactions on Electrical and Electronic Engineering, 13(10), 1501 1510) to monitor neck location and predict headache rates in humans. Audio data obtained from the microphone sensor is also used for detecting the form of cough.
Considering all the scenarios the present inventors have come up with a smart screening system that will allow people to check in different heavy public transition areas to avoid gathering in hospitals or test centres that not only reduce the risk of cross-infection with others, save the cost of test kits, and also identify the places where the infected person travels. The present invention also aims to avoid the spread of the disease as soon as possible and the whole thing will be managed through cloud computing by the Pandemic Service Controller (PSC).
1.1. Sensors: To calculate different health issues, such as respiratory rate, heart rate, heart rate variability and health issues like skin & eye disease advanced day-to-day sensors can be used. Typical health monitoring sensors are shown in Table 1.
Table 1. Typical Health Monitoring Sensors
Typical Sensors Health Issues Microphone Nasal symptoms (Blowing the nose, Sneezing and Runny Nose), Lung Functions, Ear health, chronic pulmonary diseases such as cough, asthma, shortness of breath, Fatigue level Image Sensor (Camera), Microphone Cardiovascular activity - Heart Rate, Heart Rate Variability, Respiratory and Lung Health Image Sensor (Camera) Eye Health, Skin Health Temperature, Thermal Camera Body Temperature Measurement Motion sensors (Accelerometer, Gyroscope, Physical Activity and Movements Proximity), GPS Motion sensors (Accelerometer, Gyroscope), Camera, Cognitive function and Metal health Assessment Light Sensor, GPS Motion sensors (Accelerometer, Gyroscope) Sleep GPS Track Location
Utilization ofsome typical sensors to detect the common symptoms of the diseases, like COVID-19:
3.1.1. Camera sensor: HeartRate (HR) & Rate ofRespiration (RR) assessment
Both front and rear camera sensors of smart phone were used to track both the 'heart rate' and the 'rate of Respiration' [35], where 'photoplethysmogram (PPG) fingertip signal' (from the top of the 'rear-facing camera') used to achieve the HR, In which RR is measured from the front camera by tracking chest and abdominal motions. Another way to obtain HR and RR Welch's power spectral density is required by prevailing intensity in the frequency-domain of images. On the other hand to gain 6-60 breaths (wide dynamic range) per minute as an automated selection protocol for 'Region-of-Interest (ROI)' was used. Above mentioned contact based HR monitoring systems enabling the user to direct contact through the smart phone's camera lens holding the fingertip tightly, otherwise erroneous result will obtained due to any change in finger position. At the other hand, contactless monitoring systems measure HR from the face-video-derived PPG signal. In reference Kwon S, Kim H, Park K S 2012 (Validation ofheart rate extraction using video imaging on a built-in camera system of a smartphone In Proceedings of the Annual International Conference of the IEEE Engineering in Medicine and Biology Society, San Diego, CA, USA, 28 August-i September 2012), such a contactless cardiac pulse monitoring device, called 'Face Beat', was introduced. 'Face Beat' measures the heart rhythms and determines HR from the face video taken by a user using the front camera of the smart phone. Reflected light of the increasing blood flow in the facial blood vessels on a specific section of face is detected by the photo-detector image sensor device to calculate the difference and simultaneously captured Green Channel footage data is securitized. Another proposed method Sanyal S, Nundy K K 2018 (Algorithms for Monitoring Heart Rate and RespiratoryRatefrom the Video of aUser's Face. IEEE J Transl. Eng. Heal. Med. 6, 1-11) that the colour of the reflected light is identified from the face and make the difference to obtain both RR and HR.
3.1.2. Microphone and camera sensor: HR and HR Variability (HRV) assessment
Camera and microphone are mutually being used for estimation of HR and HRV through bare skin visual 'photoplethysmogram (PPG) signal', such as the face or fingertip. The properties of haemoglobin light absorption in the blood vary from those of other body tissues including flesh and bone. PPG measures volumetric fluctuations by detecting refractive variations and/or light reflectivity with arterial pulsation through the tissue; whereas red light sources near-infrared (NIR) are used in most commercial devices. Some researchers used an embedded smart phone with a white flashlight to illuminate the PPG tissue. In reference Koenig N, Seeck A, Eckstein J, Mainka A, Huebner T, Voss A, Weber S 2016 (Validation of a New HeartRate Measurement Algorithmfor
Fingertip Recording of Video Signals with Smartphones. Telemed. e-Health, 22, 631-636) a flashlight and camera sensor from the PPG signal obtained from the fingertips were used to test the HR and HRV. The pulsing signal was extracted from the green channel of the video data after a low-frequency band-pass filtering. In corrupt video data commonly recognized by movable objects is identified and discarded. The PPG signal was extracted from all three channels (red, blue and gray) from the index fingertip video, make the difference of maximum and minimal intensity to derive the threshold then based on the threshold value aggregates the pixel values with higher intensity than the threshold. The PPG signal achieved via the red channel other than two channels the regular increase in blood flow rates during the cardiac cycles was reflected and finally applying 'Fast Fourier Transform (FFT)' analysis on this PPG signal the pulse rate was obtained at an accuracy rate about 98 percent.
3.1.3. Temperature or Thermal Camera sensor: Measure the Body Temperature
The sensor temperature-fingerprint, used to predict fever rates. Additional 'ATmega328' microcontroller for tracking patient body temperature (LM35 Temperature Sensor) and pulse (LM358 Heart Beat Sensor) is used as a CPU. In Asaduzzaman M, Hussain K, Tanveer S R et al, December 2015 (Continuous heart rate and body temperature monitoring system using Arduino UNO andAndroid device, Conference Paper - DOI: 10.1109/EICT.2015.7391943) the definition of an embedded system is demonstrated for calculating heart rate and body temperature. Another temperature monitoring sensor the thermal camera embedded with a wristband calculates the reference point temperature. In Tag B, Chernyshov G, Kunze K, 2017 (FacialTemperature Sensing on Smart Eyewearfor Affective Computing, UBICOMP/ISWC '17ADJUNCT, SEPTEMBER 11-15, 2017, MAUI, HAWAII, USA, https://doi.org/10.1145/3123024.3123084) an eye glass tracking system is implemented to follow optimistic cognitive and impulsive conditions for sentimental computing using 'Thermal IR Camera' (contactless temperature sensors) which follows changes in facial temperature.
3.1.4. Microphone Sensor: Detect Nasal symptoms (Blowing the nose, Sneezing andRunny Nose)
The application software Listen-to-Nose detects nasal symptoms that decisive on audio. The application detects sound patterns through a microphone sensor by using acoustic recognition algorithm that match blowing or sneezing (discards other audio information like speech and silence), to identify the symptoms the user has.
3.1.5. Microphone Sensor: Measure Lung Function using
"SpiroSmart" is microphone based application software that sends the recorded audio data of exhalation to a server for calculating the flow rate of exhalation to test the lung function (Chen N C, Wang K C, Chu H H, 2012 Listen-to-Nose: A low-cost system to record nasal symptoms in daily life, UbiComp'12, September 5-8, 2012, Pittsburgh, USA. ACM 978-1-4503-1224-0/12/09, https://doi.org/10.1145/2370216.2370319).A typical spirometer calculates the air flow rate when going through a mouthpiece. Such mouthpiece flow can be combined to achieve Flow vs. Time (FT), Volume vs. Time (VT), or Flow vs. Volume (FV) expiry plots. Different amounts are determined from the plot :(1) 'FVC (Forced Vital Capacity)' - During the expiry period entire volume expelled; (2) 'FEVI (Forced Expiratory Volume)' - In the first second the amount expired; (3) The ratio of FVC & and FEVI (4) 'PEF (Peak Expiratory Flow)' - The best flow rate obtained for the period of the test. Different lung dysfunctions like Mild (60-79%), Moderate (40-59%) and Severe (<40%) are obtained from the combination of flow vs. volume curves.
3.1.6. Microphone Sensor: Detect chronic respiratoryconditions (like cough, asthma, shortness of breath), pulmonary disruption and lung cancer
For faster pulmonary health assessment many researchers used a microphone sensor to detect a coughing and respiratory sound, and analysed the captured audio signals. Using built-in microphone of a smart phone based interactive game 'Flappy Breath' was developed where the users play by inhaling and exhaling to detect breathing. The game measures the occurrence and intensity of the sound inputted when playing using the microphone, determines the typical amount of air flowing referring to silence, inhalation and exhalation. To detect the coughing situation, the audio signal recorded by the smart phone's microphone was analyzed using a cough detection algorithm 'PCA' (Principal component analysis), where the cough sound spectrogram was separated, normalised and analysed on the basis of the distinct pattern and after re-generate the signal of coughing identify the coughing occurrences finally.
3.1.7. Accelerometer, gyroscopes, magnetometers, GPS, Light & Microphone Sensors: Assessment ofMental Health and PhysicalActivity & Movement
Due to variety of inbuilt embedded sensors (like accelerometer, light, GPS, microphone etc.) of today's smart phones, data such as call history, SMS history and system utilisation to track a person's behaviour remotely and determine their mental health or fatigue level (Cornet VP, Holden R J 2018 Systematic review of smartphone-basedpassive sensing for health and wellbeing. J Biomed. Inform. 77, 120-132); the accelerometer may provide information on movement and physical activity during sleep.
1.2. ProposedService Model- PandemicPreventive Measure as a service (PPMaaS)
PPMaaS under Private Cloud offers low-cost, early detection services for COVID-19 like pandemic disease with less effort to reduce cross-infection through the Smart Screening Tool. From data collection phase to decision phase the actual physical resources invoked by the Virtual Machines in such a way that once the PPMaaS model is enrolled by a customer or cloud service provider, no possibility of direct interference between users and Cloud Service Providers (CSP), as a result to avoid being partial either or both sides.
1.3. Cloud Service Provider (CSP)
A service provider that provides some storage or software or hardware or network infrastructure to the customers through SaaS or IaaS or PaaS is called a cloud service provider which not only offers services to companies or individuals, but also ensures that it takes responsibility for anything relevant to the customers' applications.
1.4. Government Health Administration System (GHAS)
The Government can create a special unit to track and deal with the pandemic situation.
1.5. Smart ScreeningDevice (SSD)
For spot diagnosis of the disease, a small device made by sensors connected to the cloud environment can be used to sense data.
1.6. PandemicService Controller (PSC)
For maintaining a smooth contact between SSD and CSP, PSC plays a major role as it compelled to register SSD and CSP's before assigning resources to the cloud server and to avoid potential conflict.
1.7. Smart PandemicDeterminer (SPD)
After receiving the periodic signals from the CSPs, SPD will use the available cloud resources and will be able to collect data from SSD, analyze it and eventually identify the disease itself. SPD therefore maintains a mapping table of PSC to its respective CSPs', as well as a log table of SSDs' connected to it.
The increasing demand for embedded sensors coupled with pay-based infrastructures and services from Evolving Cloud Computing would make it a better technology for consistent and remote monitoring of a person's health with minimal extra costs. Consider the current scenario and based on our previous observations on various cloud management services (Bose R, Biswas H, SarddarD, Sanyal M K 2016 Cloud Billing & Verification Of Consumed Resources and Storage Spaces by a Cloud User in InternationalJournalofApplied EngineeringResearch ISSN 0973-4562 Volume 11, Number 9 pp 6568-6576) we are proposing a cloud computing-based "Pandemic Preventive Measure as a service (PPMaaS)" that accommodates people for preliminary testing as an early detection of any pandemic diseases by means of low-cost sensors with less effort to mitigate cross-infection.
Figure 2 represents our proposed "PPMaaS" service model, where PSC provides users with the services from sample selection to testing phase with proper use of cloud resources and finally submits the reports to the GHAS to take the required steps.
1.8. PPMaaS model (Working Procedure)
The proposed PPMaaS model (see figure 2.), where periodic signals, report information, and available resources sent by the CSP to SPD after effective contracts. Upon acquiring resources, SPD establishes and manages the Pandemic Cloud Service such as COVID-19 or any other, and also retains the CSPs' log table for any potential reference. At the other hand, SPD provides the Pandemic Cloud Services to the SSD via PSC after receiving requests from SSD for on-demand service, and also maintains an SSD-PSC mapping table as a guide to who and from where the service is intended. According to our suggestion, in order to disperse the infection among others, the government will take the initiation as a compulsive test for mass citizens by installing SSD into public transition areas to detect any disease outbreak stops early. After installing SSD in heavily public transfer areas (such as Railway Station, Airports, Bus Terminals, Supermarket, Shopping Mall, etc.) it must be enabled with Cloud environment through a data processing service provider (here, PSC). When a client goes to a specific place to fulfil his / her requirement, he / she must go through the screening process (by SSD) before entering the location for the preliminary ongoing pandemic detection. After receiving the client's sample data SSD sends it for analysis to the PSC. At the other hand, SPD collects data from different SSDs regularly through its FETCHING module under PSC, and TESTING module is now engaged in the identification of the appropriate tools for measuring the collected samples. DETECTION module eventually takes the decision based on the evaluated result whether the person is "Infected" or "Not Infected" and sends a message to the individual. For those infected, a message along with the current location will be sent to the nearest SHC. Ultimately, SHC periodically prepares and submits Pandemic review reports to GHAS for the required action.
Our new SCPD (Smart Cloud Pandemic Detection) algorithm handles all processes automatically and also places Virtual Machines (VMs) to the actual Physical Machines (PMs) to assign the minimum amount of resources needed. Mapping the VMs' to PMs' performed by SPD under PPMaaS. So it's really clear that no one can communicate directly with each other to access this service without either the users or the CSPs' permission from the PSC. In the case of any conflict, SPD can obtain the suspected customers' comprehensive records, or CSPs, from its own SSD-PSC as well as from the PSC-CSP Mapping log table if necessary. Thus there is no chance that Cloud users may be confused or deceived by the COSP or the CSP.
1.9. Working procedure ofSmart Pandemic Determiner (SPD) Module
Figure 3 displays the different SPD sub modules and the movement from one module to another for preliminary pandemic detection. The first module i.e., the FETCHING module collects the Client samples from the SSD via the sensors embedded in it. TESTING module is now engaged for symptom prediction following sensing of the data by the respective sensors. Within this module various algorithms are embedded to evaluate the samples to predict the symptoms. Each colored line uniquely represents the flow from sample collection to the process of symptom prediction.
Let us describe some notations used for symptom prediction by TESTING module VCB - Volumetric Changes in Blood PixelIntensity -Intensity of Pixel for each frame RGBChannel - Record video through Red-Blue-Green Channel SFFT - Simple First Fourier Transform SFFTRedChannel - PPG obtained via Red Channel compared to Blue and Green Channel using Simple Fast Fourier Transform analysis Threshold -- Difference between Maximum and Minimum Intensity
/ For Heart rate, Respiratory rateDetection Image - Captured by Camera Sensor HR- Heart Rate RR - Respiration Rate BloodVessels<- Use the Green Channel captured video P_Array - The camera sensor's Photo detector Array detects light reflection (in variations) from a Specific section of the face
//For Cough and Breathing Trouble Audio_Signal -Sound (Cough, Breathing) CBT - Cough and Breathing Trouble
/ For Cough Analysis Audio_Signal -Sound (Cough, Throat _clearing, Speech, Noise) Spectogram - Contain different audio signals of Cough, Throat Clearing, Speech and Noise PCA - Principal Component Analysis which isolate spectrogram of the cough sound from other Sound CA-Cough Analysis
//For Nasal symptoms AudioData - {Blowing the nose, sneezing, runny nose, silence, speech} ARM - Acoustic Recognition Model
CD - Classified Data SVM - Support Vector Machine Nasal- Blowing the nose, sneezing, runny nose
//For Stress level detection Conversation - Recording the conversation with Microphone S_Level - Stress Level
// ForLung Dysfunction FT - FlowTime Diagram VT - Volume _Time Diagram FV - Flow _Volume Diagram FA - Flow rate of Air FVC - Forced Vital Capacity i.e., total volume emitted during expiry FEV1 - Exhaled volume in the first second R_FVCFEV1 - Ratio of FVC and FEVI PEF - Peak Expiratory Flow i.e. maximum speed of flow velocity achieved during the test DAirflow - Degree of Airflow L_Function - Lung Dysfunction i.e., Mild, Moderate or Severe
1.10. SCPD (Smart Cloud Pandemic detection) algorithm 17. Pandemic Service Controller (PSC) offers preliminary detection of Pandemic disease using Smart Screening Device (SSD) through Smart Pandemic Determiner (SPD) in cloud environment 18. SSD may be installed in important places 19. SSD collects symptoms from the Clients 20. SSD requests to PSC for diagnosing 21. PSC checks for the SSD's authentication and Service Level Agreements (SLA) 22. If Authentic 22.1 Service accepted and acknowledgement sends to the SSD 22.2 PSC requests to the intended CSP for getting the on-demand cloud resources 22.3 CSP checks for the PSC's authentication and SLA 22.4 If bona fide 22.4.1 Service established and acceptance message sends to PSC
22.4.2 Based on the agreement CSP sends the periodic signals / resource details to Smart Pandemic Determiner (SPD) 22.4.3 SPD store the record details in a log file 22.4.4 Go to step 8 22.5 Else 22.5.1 Message - "Not acknowledged for services" back to the PSC 22.5.2 Go to step 6.2 23. Else 23.1 Message - "Not accepted for services" returns to the SSD 23.2 Go to step 4 24. SPD collects the client's symptoms from the SSD by its Fetching module 25. SPD fetches the periodic record details about the resources from its log file 26. Based on the collected symptoms SPD analysis on the data by its Testing module 26.1 If within Threshold 26.1.1 "Not Infected" -- message returned to the SSD as well as to the Client 26.1.2 Go to step 11 26.2 Else 26.2.1 SPD trace the current location of the infected person 26.2.2 "Infected" -- message returned to the SSD, to the Client, as well as to the nearest Sanatorium / Health Centre (SHC) with details about the Client 27. Check for the availability of the client 28. If client exists 28.1 Go to step 3 29. Else 13.1 Go to step 14 30. SHC sends the pandemic reports to the Government Health Management System (GHAS) 31. GHAS takes necessary actions 32. End
The end result of our approach is to create a portable testing device with an efficient interface that can be incorporated as part of the patient safety management system into medical and home equipment. Approached PPMaaS model recognizes actual physical server load next to VM user constraints addressing the mapping problem of client 's tasks into actual servers in such a way that not only reduce the number of nodes used, also the physical machines with overuse or underuse can be defined and resolved simultaneously without violating any Service Quality and Service Level Agreements. Since we consider this to be a pandemic tool that not only serves as an early detection of pandemic diseases to prevent cross-infection, also it acts as an intermediary between clients and CSPs', ensuring that nobody can communicate with each other without PSC's permission. This will eliminate the inequity between the customers 'actual usage of energy with the billing records by the suppliers', therefore avoiding any fake claims that might be brought against one another in order to get unlawful compensation.
Based on the present critical pandemic situation (COVID-19) much of the work on the COVID-19 analysis of our proposed model has been covered. The result analysis can be performed after implementation of the model. Our target is to increase the QoS with costs savings and in near future our aim is to accomplish more cloud computing capacity to battle other pandemic diseases from home as soon as possible at lower prices, less overheads.
Claims (5)
1. An IoT-based smart pandemic detection device on a cloud-oriented architecture Pandemic Preventive Measure as a Service (PPMaaS) network for early tracking of any pandemic disease affected populations, deploying in crowd transition areas and taking precautions by contacting nearest relevant hospitals to access treatment immediately based on the condition of the patients, wherein the device based on an A enabled cloud computing based framework comprising Smart Pandemic Determiner (SPD) under Pandemic Service Controller (PSC) expertise, operates from sample collection to detection phase based on the available resources provided by the respective cloud service provide (CSP) and sends the result to the Government Health Administration System (GHAS) through nearest Sanatorium or Health Centre (SHC) for preventive measure.
2. The device as claimed in claim 1, wherein it collects data from wide range of sensors such as temperature, cameras, inertial, proximity, microphones, colour, humidity, and likes.
3. The device as claimed in claims 1 to 2, wherein the Al enabled cloud computing based framework combines the usage of the sensors with cloud environment, converted it into a smarter portable system to gain more access and analyse power for COVID-19 like pandemic detection.
4. The device as claimed in claims 1 to 3, wherein - to calculate different health issues, such as respiratory rate, heart rate, heart rate variability and health issues like skin & eye disease a advanced day-to-day sensors is used; - to track both the 'heart rate' and the 'rate of Respiration' the front and rear camera sensors of a smart phone is used and wherein 'photoplethysmogram (PPG) fingertip signal' from the top of the 'rear-facing camera' is used to achieve the heart rate; - for estimation of heart rate and heart rate variability through bare skin visual 'photoplethysmogram (PPG) signal' camera and microphone are mutually being used; - to predict fever, the sensor temperature-fingerprint is used; - to detect nasal symptoms, the application software Listen-to-Nose is used; - to test the lung function "SpiroSmart" is microphone based application software is used;
- to detect a coughing and respiratory sound microphone sensor is used; - to assess mental health and physical activity and movement, embedded sensors like accelerometer, light, GPS, microphone etc. are used.
5. The device as claimed in claims 1 to 4, wherein the Cloud Service Provider (CSP) provides storage or software or hardware or network infrastructure to the customers through SaaS or IaaS or PaaS.
6. The device as claimed in claims 1 to 5, wherein the Government can create a special unit to track and deal with the pandemic situation.
7. The device as claimed in claims 1 to 6, wherein for spot diagnosis of the disease, a small device made by sensors connected to the cloud environment is used to sense data.
8. The device as claimed in claims 1 to 7, wherein for maintaining a smooth contact between SSD and CSP, PSC plays a major role as it compelled to register SSD and CSP's before assigning resources to the cloud server and to avoid potential conflict; and wherein after receiving the periodic signals from the CSPs, SPD will use the available cloud resources and will be able to collect data from SSD, analyze it and eventually identify the disease itself.
9. The device as claimed in claims 1 to 8, where the device provides for a portable testing device with an efficient interface that can be incorporated as part of the patient safety management system into medical and home equipment
10. An IoT-based smart pandemic detection method on a cloud-oriented architecture Pandemic Preventive Measure as a Service (PPMaaS) network for early tracking of any pandemic disease affected populations, deploying in crowd transition areas and taking precautions by contacting nearest relevant hospitals to access treatment immediately based on the condition of the patients, wherein it comprises the following SCPD (Smart Cloud Pandemic detection) algorithm: 1. Pandemic Service Controller (PSC) offers preliminary detection of Pandemic disease using Smart Screening Device (SSD) through Smart Pandemic Determiner (SPD) in cloud environment 2. SSD may be installed in important places
3. SSD collects symptoms from the Clients 4. SSD requests to PSC for diagnosing 5. PSC checks for the SSD's authentication and Service Level Agreements (SLA) 6. If Authentic 6.1 Service accepted and acknowledgement sends to the SSD 6.2 PSC requests to the intended CSP for getting the on-demand cloud resources 6.3 CSP checks for the PSC's authentication and SLA 6.4 If bona fide 6.4.1 Service established and acceptance message sends to PSC 6.4.2 Based on the agreement CSP sends the periodic signals / resource details to Smart Pandemic Determiner (SPD) 6.4.3 SPD store the record details in a log file 6.4.4 Go to step 8 6.
5 Else 6.5.1 Message - "Not acknowledged for services" back to the PSC 6.5.2 Go to step 6.2 7. Else 7.1 Message - "Not accepted for services" returns to the SSD 7.2 Go to step 4 8. SPD collects the client's symptoms from the SSD by its Fetching module 9. SPD fetches the periodic record details about the resources from its log file 10. Based on the collected symptoms SPD analysis on the data by its Testing module 10.1 If within Threshold 10.1.1 "Not Infected" -- message returned to the SSD as well as to the Client 10.1.2 Go to step 11 10.2 Else 10.2.1 SPD trace the current location of the infected person 10.2.2 "Infected" -- message returned to the SSD, to the Client, as well as to the nearest Sanatorium / Health Centre (SHC) with details about the Client 11. Check for the availability of the client 12. If client exists 12.1 Go to step 3 13. Else 13.1 Go to step 14
14. SHC sends the pandemic reports to the Government Health Management System (GHAS) 15. GHAS takes necessary actions 16. End
Page 1 of 4
DRAWINGS 27 Jun 2021 2021103658
Figure 1. Proposed Service Model including basicCloud Service Models
2021103658 Page 2 of 4
Figure 2. Proposed Architecture of Pandemic Preventive Measure as a service (PPMaaS) Model
2021103658 Page 3 of 4
Figure 3. Process Flow Diagram of Smart Pandemic Determiner (SPD)
2021103658 Page 4 of 4
Figure 4. Flowchart of PPMaaS Model
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2021103658A AU2021103658A4 (en) | 2021-06-27 | 2021-06-27 | Iot based smart pandemic detection device and method for pandemic preventive measures |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2021103658A AU2021103658A4 (en) | 2021-06-27 | 2021-06-27 | Iot based smart pandemic detection device and method for pandemic preventive measures |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2021103658A4 true AU2021103658A4 (en) | 2022-03-31 |
Family
ID=80855652
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2021103658A Ceased AU2021103658A4 (en) | 2021-06-27 | 2021-06-27 | Iot based smart pandemic detection device and method for pandemic preventive measures |
Country Status (1)
Country | Link |
---|---|
AU (1) | AU2021103658A4 (en) |
-
2021
- 2021-06-27 AU AU2021103658A patent/AU2021103658A4/en not_active Ceased
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Rohmetra et al. | AI-enabled remote monitoring of vital signs for COVID-19: methods, prospects and challenges | |
Al Bassam et al. | IoT based wearable device to monitor the signs of quarantined remote patients of COVID-19 | |
García et al. | An m-health application for cerebral stroke detection and monitoring using cloud services | |
Fekr et al. | Respiration disorders classification with informative features for m-health applications | |
Hassan et al. | Towards health monitoring using remote heart rate measurement using digital camera: A feasibility study | |
US20240120100A1 (en) | Predicting respiratory distress | |
Emokpae et al. | Smart multimodal telehealth-IoT system for COVID-19 patients | |
KR102239557B1 (en) | Bio-signal analysis algorithm, system and method | |
Zhang et al. | A framework for remote interaction and management of home care elderly adults | |
Mali et al. | Targeting infectious coronavirus disease 2019 (COVID-19) with artificial intelligence (AI) applications: Evidence based opinion | |
AU2021103658A4 (en) | Iot based smart pandemic detection device and method for pandemic preventive measures | |
US10925548B2 (en) | Device, system and method for detection of an asthma attack or asthma of a subject | |
Mo et al. | The role of edge robotics as-a-service in monitoring COVID-19 infection | |
Fikry et al. | Improving Complex Nurse Care Activity Recognition Using Barometric Pressure Sensors | |
Biswas et al. | COVID-19 on spot detection as a service (COSDaaS)–A cloud-based pandemic service approach by means of a smart screening device for mass screening to minimize the spread of infection efficiently. | |
Bennett et al. | The assessment of cognitive and physical well-being through ambient sensor measures of movement towards longitudinal monitoring of activities of daily living | |
WO2024025932A1 (en) | Method and apparatus for detecting conditions from physiology data | |
Liu et al. | Tidal volume estimation using portable ultrasound imaging system | |
Aldred et al. | Application of thermography to estimate respiratory rate in the emergency room: the journal temperature toolbox | |
US20230290506A1 (en) | Systems and methods for rapidly screening for signs and symptoms of disorders | |
Khawandi et al. | Integrated monitoring system for fall detection in elderly | |
US20160228067A1 (en) | System and method for intelligent monitoring of patient vital signs | |
US20170364650A1 (en) | Managing a therapeutic state based on cognitive, contextual, and location-based action recognition | |
Avuthu et al. | A Deep Learning approach for detection and analysis of respiratory infections in covid-19 patients using RGB and infrared images. | |
Uwaoma et al. | Using embedded sensors in smartphones to monitor and detect early symptoms of exercise-induced asthma |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FGI | Letters patent sealed or granted (innovation patent) | ||
MK22 | Patent ceased section 143a(d), or expired - non payment of renewal fee or expiry |